230 related articles for article (PubMed ID: 29870298)
1. Utility of the Surgical Apgar Score in Head and Neck Squamous Cell Carcinoma.
Prince AC; Day KE; Lin CP; Greene BJ; Carroll WR
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):466-472. PubMed ID: 29870298
[TBL] [Abstract][Full Text] [Related]
2. Utility of the Modified Surgical Apgar Score in a Head and Neck Cancer Population.
Day KE; Prince AC; Lin CP; Greene BJ; Carroll WR
Otolaryngol Head Neck Surg; 2018 Jul; 159(1):68-75. PubMed ID: 29436276
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
4. A novel classification system for perineural invasion in noncutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes.
Miller ME; Palla B; Chen Q; Elashoff DA; Abemayor E; St John MA; Lai CK
Am J Otolaryngol; 2012; 33(2):212-5. PubMed ID: 22177613
[TBL] [Abstract][Full Text] [Related]
5. Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
Hamilton SN; Tran E; Berthelet E; Wu J; Olson R
Head Neck; 2018 Nov; 40(11):2432-2440. PubMed ID: 30295975
[TBL] [Abstract][Full Text] [Related]
6. A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence.
Saidak Z; Clatot F; Chatelain D; Galmiche A
Oral Oncol; 2018 Nov; 86():53-60. PubMed ID: 30409320
[TBL] [Abstract][Full Text] [Related]
7. Developing a risk stratification tool for audit of outcome after surgery for head and neck squamous cell carcinoma.
Tighe DF; Thomas AJ; Sassoon I; Kinsman R; McGurk M
Head Neck; 2017 Jul; 39(7):1357-1363. PubMed ID: 28370624
[TBL] [Abstract][Full Text] [Related]
8. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
Head Neck; 2018 Apr; 40(4):728-739. PubMed ID: 29272056
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
[TBL] [Abstract][Full Text] [Related]
11. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
12. All-Cause 30-Day Mortality After Surgical Treatment for Head and Neck Squamous Cell Carcinoma in the United States.
Bukatko AR; Patel PB; Kakarla V; Simpson MC; Adjei Boakye E; Patel SH; Stamatakis KA; Varvares MA; Osazuwa-Peters N
Am J Clin Oncol; 2019 Jul; 42(7):596-601. PubMed ID: 31166207
[TBL] [Abstract][Full Text] [Related]
13. Preoperative anemia and perioperative blood transfusion in head and neck squamous cell carcinoma.
Baumeister P; Canis M; Reiter M
PLoS One; 2018; 13(10):e0205712. PubMed ID: 30347001
[TBL] [Abstract][Full Text] [Related]
14. Non-HPV-Related Head and Neck Squamous Cell Carcinoma in a Young Patient Cohort.
Dougherty MI; Dougherty W; Kain JJ; Hughley BB; Shonka DC; Fedder KL; Jameson MJ
Ear Nose Throat J; 2021 Dec; 100(10_suppl):1101S-1106S. PubMed ID: 32584613
[TBL] [Abstract][Full Text] [Related]
15. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Occult Lymph Node Metastasis in Head and Neck Cancer with CD31 Vessel Quantification.
Mermod M; Bongiovanni M; Petrova T; Goun E; Simon C; Tolstonog G; Monnier Y
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):277-283. PubMed ID: 30084319
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection.
Zhou S; Yuan H; Wang J; Hu X; Liu F; Zhang Y; Jiang B; Zhang W
Future Oncol; 2020 Apr; 16(10):559-571. PubMed ID: 32166977
[No Abstract] [Full Text] [Related]
18. Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell Carcinoma.
Jorgensen JB; Smith RB; Coughlin A; Spanos WC; Lohr MM; Sperry SM; Militsakh O; Zitsch RP; Yueh B; Dooley LM; Panwar A; Galloway TLI; Pagedar NA
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):261-266. PubMed ID: 30126337
[TBL] [Abstract][Full Text] [Related]
19. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
[TBL] [Abstract][Full Text] [Related]
20. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.
Mäkitie AA; Almangush A; Rodrigo JP; Ferlito A; Leivo I
Head Neck; 2019 Oct; 41(10):3712-3718. PubMed ID: 31328847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
